Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures
Blog Posts
WCG Clinical | Insights
Is informed consent needed for post-market patient registry?
Blog Posts
WCG Clinical | Insights
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
WCG Clinical | Insights
What are the IRB review requirements for human factors/usability testing?
Blog Posts
WCG Clinical | Insights
Five Tips for Improving Your Site’s Study Start-Up Timelines
Blog Posts
WCG Clinical | Insights
Choosing Between Provisioned, BYOD, and Hybrid Models for ePRO: Which Is Right for Your Clinical Trial?
Blog Posts
WCG Clinical | Insights
A Successful DMC Requires a Productive, Early Organizational Meeting
Blog Posts
WCG Clinical | Insights
Five Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site
Blog Posts
WCG Clinical | Insights
Ask the Experts: When Do I Report a Protocol Deviation to the IRB? Do I Need To Report a Summary of Deviations at the Time of Continuing Review?
Blog Posts
WCG Clinical | Insights